Skip to main content
Erschienen in: Osteoporosis International 11/2014

01.11.2014 | Original Article

The risk of major and any (non-hip) fragility fracture after hip fracture in the United Kingdom: 2000–2010

verfasst von: D. Gibson-Smith, C. Klop, P. J. M. Elders, P. M. J. Welsing, N. van Schoor, H. G. M. Leufkens, N. C. Harvey, T. P. van Staa, F. de Vries

Erschienen in: Osteoporosis International | Ausgabe 11/2014

Einloggen, um Zugang zu erhalten

Abstract

Summary

The risk of a subsequent major or any fracture after a hip fracture and secular trends herein were examined. Within 1 year, 2.7 and 8.4 % of patients sustained a major or any (non-hip) fracture, which increased to 14.7 and 32.5 % after 5 years. Subsequent fracture rates increased during the study period both for major and any (non-hip) fracture.

Introduction

Hip fractures are associated with subsequent fractures, particularly in the year following initial fracture. Age-adjusted hip fracture rates have stabilised in many developed countries, but secular trends in subsequent fracture remain poorly documented. We thus evaluated secular trends (2000–2010) and determinants for the risk of a subsequent major (humerus, vertebral, or forearm) and any (non-hip) fracture after hip fracture.

Methods

Patients ≥50 years with a hip fracture between 2000 and 2010 were extracted from the UK Clinical Practice Research Datalink (n = 30,516). Incidence rates, cumulative incidence probabilities, and adjusted hazard ratios (aHRs) were calculated.

Results

Within 1 year following hip fracture, 2.7 and 8.4 % of patients sustained a major or any (non-hip) fracture, which increased to 14.7 and 32.5 % after 5 years, respectively. The most important risk factors for a subsequent major fracture within 1 year were the female gender [aHR 1.90, 95 % confidence interval (CI) 1.51–2.40] and a history of secondary osteoporosis (aHR 1.54, 95 % CI 1.17–2.02). The annual risk increased during the study period for both subsequent major (2009–2010 vs. 2000–2002: aHR 1.44, 95 % CI 1.12–1.83) and any (non-hip) facture (2009–2010 vs. 2000–2002: aHR 1.80, 95 % CI 1.58–2.06).

Conclusion

The risk of sustaining a major or any (non-hip) fracture after hip fracture is small in the first year. However, given the recent rise in secondary fracture rates and the substantial risk of subsequent fracture in the longer term, fracture prevention is clearly indicated for patients who have sustained a hip fracture.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Lee YK, Lee YJ, Ha YC, Koo KH (2014) Five-year relative survival of patients with osteoporotic hip fracture. J Clin Endocrinol Metab 99:97–100PubMedCrossRef Lee YK, Lee YJ, Ha YC, Koo KH (2014) Five-year relative survival of patients with osteoporotic hip fracture. J Clin Endocrinol Metab 99:97–100PubMedCrossRef
2.
Zurück zum Zitat Bertran M, Norman R, Kemp L, Vos T (2011) Review of the long-term disability associated with hip fractures. Inj Prev 17:365–370CrossRef Bertran M, Norman R, Kemp L, Vos T (2011) Review of the long-term disability associated with hip fractures. Inj Prev 17:365–370CrossRef
3.
Zurück zum Zitat Ryg J, Rejnmark L, Overgaard S, Brixen K, Vestergaard P (2009) Hip fracture patients at risk of second hip fracture: a nationwide population-based cohort study of 169,145 cases during 1977–2001. J Bone Miner Res 24:1299–1307PubMedCrossRef Ryg J, Rejnmark L, Overgaard S, Brixen K, Vestergaard P (2009) Hip fracture patients at risk of second hip fracture: a nationwide population-based cohort study of 169,145 cases during 1977–2001. J Bone Miner Res 24:1299–1307PubMedCrossRef
4.
Zurück zum Zitat Klotzbuecher CM, Ross PD, Landsman PB, Abbott TA 3rd, Berger M (2000) Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 15:721–739PubMedCrossRef Klotzbuecher CM, Ross PD, Landsman PB, Abbott TA 3rd, Berger M (2000) Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 15:721–739PubMedCrossRef
5.
Zurück zum Zitat Warriner AH, Patkar NM, Yun H, Delzell E (2012) Minor, major, low-trauma, and high-trauma fractures: what are the subsequent fracture risks and how do they vary? Curr Osteoporos Rep 10:22–27CrossRef Warriner AH, Patkar NM, Yun H, Delzell E (2012) Minor, major, low-trauma, and high-trauma fractures: what are the subsequent fracture risks and how do they vary? Curr Osteoporos Rep 10:22–27CrossRef
6.
Zurück zum Zitat Huntjens KM, Kosar S, van Geel TA, Geusens PP, Willems P, Kessels A, Brink P, van Helden S (2010) Risk of subsequent fracture and mortality within 5 years after a non-vertebral fracture. Osteoporos Int 21:2075–2082PubMedCrossRefPubMedCentral Huntjens KM, Kosar S, van Geel TA, Geusens PP, Willems P, Kessels A, Brink P, van Helden S (2010) Risk of subsequent fracture and mortality within 5 years after a non-vertebral fracture. Osteoporos Int 21:2075–2082PubMedCrossRefPubMedCentral
7.
Zurück zum Zitat Johnell O, Kanis JA, Odén A, Sernbo I, Redlund-Johnell I, Petterson C, De Laet C, Jönsson B (2004) Fracture risk following an osteoporotic fracture. Osteoporos Int 15:175–179PubMedCrossRef Johnell O, Kanis JA, Odén A, Sernbo I, Redlund-Johnell I, Petterson C, De Laet C, Jönsson B (2004) Fracture risk following an osteoporotic fracture. Osteoporos Int 15:175–179PubMedCrossRef
8.
Zurück zum Zitat van Helden S, Cals J, Kessels F, Brink P, Dinant GJ, Geusens P (2006) Risk of new clinical fractures within 2 years following a fracture. Osteoporos Int 17:348–354PubMedCrossRef van Helden S, Cals J, Kessels F, Brink P, Dinant GJ, Geusens P (2006) Risk of new clinical fractures within 2 years following a fracture. Osteoporos Int 17:348–354PubMedCrossRef
9.
Zurück zum Zitat von Friesendorff M, Besjakov J, Akesson K (2008) Long-term survival and fracture risk after hip fracture: a 22-year follow-up in women. J Bone Miner Res 23:1832–1841CrossRef von Friesendorff M, Besjakov J, Akesson K (2008) Long-term survival and fracture risk after hip fracture: a 22-year follow-up in women. J Bone Miner Res 23:1832–1841CrossRef
10.
Zurück zum Zitat van Geel TA, van Helden S, Geusens PP, Winkens B, Dinant GJ (2009) Clinical subsequent fractures cluster in time after first fractures. Ann Rheum Dis 68:99–102PubMedCrossRef van Geel TA, van Helden S, Geusens PP, Winkens B, Dinant GJ (2009) Clinical subsequent fractures cluster in time after first fractures. Ann Rheum Dis 68:99–102PubMedCrossRef
11.
Zurück zum Zitat Sawalha S, Parker MJ (2012) Characteristics and outcome in patients sustaining a second contralateral fracture of the hip. J Bone Joint Surg (Br) 94:102–106CrossRef Sawalha S, Parker MJ (2012) Characteristics and outcome in patients sustaining a second contralateral fracture of the hip. J Bone Joint Surg (Br) 94:102–106CrossRef
12.
Zurück zum Zitat Bliuc D, Nguyen ND, Milch VE, Nguyen TV, Eisman JA, Center JR (2009) Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA 301:513–521PubMedCrossRef Bliuc D, Nguyen ND, Milch VE, Nguyen TV, Eisman JA, Center JR (2009) Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA 301:513–521PubMedCrossRef
13.
Zurück zum Zitat Pearse EO, Redfern DJ, Sinha M, Edge AJ (2003) Outcome following a second hip fracture. Injury 34:518–521PubMedCrossRef Pearse EO, Redfern DJ, Sinha M, Edge AJ (2003) Outcome following a second hip fracture. Injury 34:518–521PubMedCrossRef
14.
Zurück zum Zitat Cooper C, Cole ZA, Holroyd CR, Earl SC, Harvey NC, Dennison EM, Melton LJ, Cummings SR, Kanis JA (2011) Secular trends in the incidence of hip and other osteoporotic fractures. Osteoporos Int 22:1277–1288PubMedCrossRefPubMedCentral Cooper C, Cole ZA, Holroyd CR, Earl SC, Harvey NC, Dennison EM, Melton LJ, Cummings SR, Kanis JA (2011) Secular trends in the incidence of hip and other osteoporotic fractures. Osteoporos Int 22:1277–1288PubMedCrossRefPubMedCentral
15.
Zurück zum Zitat Alves SM, Economou T, Oliveira C, Ribeiro AL, Neves N, Gomez-Barrena E, Pina MF (2013) Osteoporotic hip fractures: bisphosphonates sales and observed turning point in trend. A population based retrospective study. Bone 53:430–436PubMedCrossRef Alves SM, Economou T, Oliveira C, Ribeiro AL, Neves N, Gomez-Barrena E, Pina MF (2013) Osteoporotic hip fractures: bisphosphonates sales and observed turning point in trend. A population based retrospective study. Bone 53:430–436PubMedCrossRef
16.
Zurück zum Zitat Turkington P, Madonald S, Elliott J, Beringer T (2012) Hip fracture in Northern Ireland, 1985–2010. Are age specific rates still rising? Ulster Med J 81:123–126PubMedPubMedCentral Turkington P, Madonald S, Elliott J, Beringer T (2012) Hip fracture in Northern Ireland, 1985–2010. Are age specific rates still rising? Ulster Med J 81:123–126PubMedPubMedCentral
17.
Zurück zum Zitat Melton LJ III, Therneau TM, Larson DR (1998) Long-term trends in hip fracture prevalence: the influence of hip fracture incidence and survival. Osteoporos Int 8:68–74PubMedCrossRef Melton LJ III, Therneau TM, Larson DR (1998) Long-term trends in hip fracture prevalence: the influence of hip fracture incidence and survival. Osteoporos Int 8:68–74PubMedCrossRef
18.
Zurück zum Zitat National Institute for Clinical Excellence (2005) Technology appraisal guidance 87 bisphosphonates (alendronate, etidronate, risedronate), selective oestrogen receptor modulators (raloxifene) and parathyroid hormone (teriparatide) for the secondary prevention of osteoporotic fragility fractures in postmenopausal women National Institute for Clinical Excellence (2005) Technology appraisal guidance 87 bisphosphonates (alendronate, etidronate, risedronate), selective oestrogen receptor modulators (raloxifene) and parathyroid hormone (teriparatide) for the secondary prevention of osteoporotic fragility fractures in postmenopausal women
19.
Zurück zum Zitat Omsland TK, Holvik K, Meyer HE, Center JR, Emaus N, Tell GS, Schei B, Tverdal A, Gjesdal CG, Grimnes G, Forsmo S, Eisman JA, Søgaard AJ (2012) Hip fractures in Norway 1999–2008: time trends in total incidence and second hip fracture rates: a NOREPOS study. Eur J Epidemiol 27:807–814PubMedCrossRef Omsland TK, Holvik K, Meyer HE, Center JR, Emaus N, Tell GS, Schei B, Tverdal A, Gjesdal CG, Grimnes G, Forsmo S, Eisman JA, Søgaard AJ (2012) Hip fractures in Norway 1999–2008: time trends in total incidence and second hip fracture rates: a NOREPOS study. Eur J Epidemiol 27:807–814PubMedCrossRef
20.
Zurück zum Zitat Melton LJ 3rd, Kearns AE, Atkinson EJ, Bolander ME, Achenbach SJ, Huddleston JM, Therneau TM, Leibson CL (2009) Secular trends in hip fracture incidence and recurrence. Osteoporos Int 20:687–694PubMedCrossRefPubMedCentral Melton LJ 3rd, Kearns AE, Atkinson EJ, Bolander ME, Achenbach SJ, Huddleston JM, Therneau TM, Leibson CL (2009) Secular trends in hip fracture incidence and recurrence. Osteoporos Int 20:687–694PubMedCrossRefPubMedCentral
21.
Zurück zum Zitat Kanis JA, Mc Closkey EV, Johansson H, Oden A, Ström O, Borgström F (2010) Development and use of FRAX in osteoporosis. Osteoporos Int 21:407–413CrossRef Kanis JA, Mc Closkey EV, Johansson H, Oden A, Ström O, Borgström F (2010) Development and use of FRAX in osteoporosis. Osteoporos Int 21:407–413CrossRef
22.
Zurück zum Zitat Van Staa TP, Abenhaim L, Cooper C, Zhang B, Leufkens HG (2000) The use of a large pharmacoepidemiological database to study exposure to oral corticosteroids and risk of fractures: validation of study population and results. Pharmacoepidemiol Drug Saf 9:359–366PubMedCrossRef Van Staa TP, Abenhaim L, Cooper C, Zhang B, Leufkens HG (2000) The use of a large pharmacoepidemiological database to study exposure to oral corticosteroids and risk of fractures: validation of study population and results. Pharmacoepidemiol Drug Saf 9:359–366PubMedCrossRef
23.
Zurück zum Zitat Warriner A, Patkar N, Curtis J, Delzell E, Gary L, Kilgore M, Saag K (2011) Which fractures are most attributable to osteoporosis? J Clin Epidemiol 64:46–53PubMedCrossRef Warriner A, Patkar N, Curtis J, Delzell E, Gary L, Kilgore M, Saag K (2011) Which fractures are most attributable to osteoporosis? J Clin Epidemiol 64:46–53PubMedCrossRef
24.
Zurück zum Zitat Ström O, Borgström F, Kanis JA, Compston J, Cooper C, McCloskey EV, Jönsson B (2011) Osteoporosis: burden, health care provision and opportunities in the EU. Arch Osteoporos 6:59–155PubMedCrossRef Ström O, Borgström F, Kanis JA, Compston J, Cooper C, McCloskey EV, Jönsson B (2011) Osteoporosis: burden, health care provision and opportunities in the EU. Arch Osteoporos 6:59–155PubMedCrossRef
25.
Zurück zum Zitat Egan M, Jaglal S, Byrne K, Wells J, Stolee P (2008) Factors associated with a second hip fracture: a systematic review. Clin Rehabil 22:272–282PubMedCrossRef Egan M, Jaglal S, Byrne K, Wells J, Stolee P (2008) Factors associated with a second hip fracture: a systematic review. Clin Rehabil 22:272–282PubMedCrossRef
26.
Zurück zum Zitat Colón-Emeric CS, Lyles KW, Su G, Pieper CF, Magaziner JS, Adachi JD, Bucci-Rechtweg CM, Haentjens P, Boonen S (2011) Clinical risk factors for recurrent fracture after hip fracture: a prospective study. Calcif Tissue Int 88:425–431PubMedCrossRef Colón-Emeric CS, Lyles KW, Su G, Pieper CF, Magaziner JS, Adachi JD, Bucci-Rechtweg CM, Haentjens P, Boonen S (2011) Clinical risk factors for recurrent fracture after hip fracture: a prospective study. Calcif Tissue Int 88:425–431PubMedCrossRef
27.
28.
Zurück zum Zitat Woolcott JC, Richardson KJ, Wiens MO, Patel B, Marin J, Khan KM, Marra CA (2009) Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med 169:1952–1960PubMedCrossRef Woolcott JC, Richardson KJ, Wiens MO, Patel B, Marin J, Khan KM, Marra CA (2009) Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med 169:1952–1960PubMedCrossRef
29.
Zurück zum Zitat Carbone LD, Johnson KC, Robbins J, Larson JC, Curb JD, Watson K, Gass M, Lacroix AZ (2010) Antiepileptic drug use, falls, fractures, and BMD in postmenopausal women: findings from the women's health initiative (WHI). J Bone Miner Res 25:873–881PubMedPubMedCentral Carbone LD, Johnson KC, Robbins J, Larson JC, Curb JD, Watson K, Gass M, Lacroix AZ (2010) Antiepileptic drug use, falls, fractures, and BMD in postmenopausal women: findings from the women's health initiative (WHI). J Bone Miner Res 25:873–881PubMedPubMedCentral
30.
31.
Zurück zum Zitat Hagino H, Sawaguchi T, Endo N, Ito Y, Nakano T, Watanabe Y (2012) The risk of second hip fracture in patients after their first hip fracture. Calcif Tissue Int 90:14–21PubMedCrossRef Hagino H, Sawaguchi T, Endo N, Ito Y, Nakano T, Watanabe Y (2012) The risk of second hip fracture in patients after their first hip fracture. Calcif Tissue Int 90:14–21PubMedCrossRef
32.
Zurück zum Zitat Budicǎ CR, Cristea ŞT, Panait GH (2010) Risk assessment of new fracture following fragility hip fracture. Arch Balk Med Union 45:40–48 Budicǎ CR, Cristea ŞT, Panait GH (2010) Risk assessment of new fracture following fragility hip fracture. Arch Balk Med Union 45:40–48
33.
Zurück zum Zitat Curtis JR, Arora T, Matthews RS, Taylor A, Becker DJ, Colon-Emeric C, Kilgore ML, Morrisey MA, Saag KG, Safford MM, Warriner A, Delzell E (2010) Is withholding osteoporosis medication after fracture sometimes rational? A comparison of the risk for second fracture versus death. J Am Med Dir Assoc 11:584–591PubMedCrossRefPubMedCentral Curtis JR, Arora T, Matthews RS, Taylor A, Becker DJ, Colon-Emeric C, Kilgore ML, Morrisey MA, Saag KG, Safford MM, Warriner A, Delzell E (2010) Is withholding osteoporosis medication after fracture sometimes rational? A comparison of the risk for second fracture versus death. J Am Med Dir Assoc 11:584–591PubMedCrossRefPubMedCentral
34.
Zurück zum Zitat Chen JS, Sambrook PN, Simpson JM, Cameron ID, Cumming RG, Seibel MJ et al (2009) Risk factors for hip fracture among institutionalised older people. Age Ageing 38:429–434PubMedCrossRef Chen JS, Sambrook PN, Simpson JM, Cameron ID, Cumming RG, Seibel MJ et al (2009) Risk factors for hip fracture among institutionalised older people. Age Ageing 38:429–434PubMedCrossRef
35.
Zurück zum Zitat Thomas SL, Edwards CJ, Smeeth L, Cooper C, Hall AJ (2008) How accurate are diagnoses for rheumatoid arthritis and juvenile idiopathic arthritis in the general practice research database? Arthritis 59:1314–1321CrossRef Thomas SL, Edwards CJ, Smeeth L, Cooper C, Hall AJ (2008) How accurate are diagnoses for rheumatoid arthritis and juvenile idiopathic arthritis in the general practice research database? Arthritis 59:1314–1321CrossRef
36.
Zurück zum Zitat Smith P, Ariti C, Bardsley M (2013) Focus on hip fracture: trends in emergency admission for fractured neck of femur, 2001 to 2011. Nuffield Trust/Health Foundation Smith P, Ariti C, Bardsley M (2013) Focus on hip fracture: trends in emergency admission for fractured neck of femur, 2001 to 2011. Nuffield Trust/Health Foundation
38.
Zurück zum Zitat Watson J, Wise L, Green J (2007) Prescribing hormone therapy for menopause, tibolone and bisphosphonates in women in the UK between 1991 and 2005. Eur J Clin Pharmacol 63:843–849PubMedCrossRef Watson J, Wise L, Green J (2007) Prescribing hormone therapy for menopause, tibolone and bisphosphonates in women in the UK between 1991 and 2005. Eur J Clin Pharmacol 63:843–849PubMedCrossRef
39.
Zurück zum Zitat Cadarette SM, Katz JN, Brookhart MA, Levin R, Stedman MR, Choudhry NK, Solomon DH (2008) Trends in drug prescribing for osteoporosis after hip fracture, 1995–2004. J Rheumatol 35:319–326PubMedPubMedCentral Cadarette SM, Katz JN, Brookhart MA, Levin R, Stedman MR, Choudhry NK, Solomon DH (2008) Trends in drug prescribing for osteoporosis after hip fracture, 1995–2004. J Rheumatol 35:319–326PubMedPubMedCentral
Metadaten
Titel
The risk of major and any (non-hip) fragility fracture after hip fracture in the United Kingdom: 2000–2010
verfasst von
D. Gibson-Smith
C. Klop
P. J. M. Elders
P. M. J. Welsing
N. van Schoor
H. G. M. Leufkens
N. C. Harvey
T. P. van Staa
F. de Vries
Publikationsdatum
01.11.2014
Verlag
Springer London
Erschienen in
Osteoporosis International / Ausgabe 11/2014
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-014-2799-x

Weitere Artikel der Ausgabe 11/2014

Osteoporosis International 11/2014 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Mehr Frauen im OP – weniger postoperative Komplikationen

21.05.2024 Allgemeine Chirurgie Nachrichten

Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

TEP mit Roboterhilfe führt nicht zu größerer Zufriedenheit

15.05.2024 Knie-TEP Nachrichten

Der Einsatz von Operationsrobotern für den Einbau von Totalendoprothesen des Kniegelenks hat die Präzision der Eingriffe erhöht. Für die postoperative Zufriedenheit der Patienten scheint das aber unerheblich zu sein, wie eine Studie zeigt.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.